Cargando…
Anti-TNF-α Monoclonal Antibody Therapy Improves Anemia through Downregulating Hepatocyte Hepcidin Expression in Inflammatory Bowel Disease
Anemia is one of the most common complications in patients with inflammatory bowel disease (IBD). Hepcidin as a key regulator of iron metabolism is pivotal in mediating the occurrence of anemia of chronic disease. Herein, we analyzed the levels of hepcidin in sera from IBD patients by enzyme-linked...
Autores principales: | Shu, Weigang, Pang, Zhi, Xu, Chunjin, Lin, Jian, Li, Gengfeng, Wu, Wei, Sun, Suofeng, Li, Junxiang, Li, Xiuling, Liu, Zhanju |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6878771/ https://www.ncbi.nlm.nih.gov/pubmed/31814801 http://dx.doi.org/10.1155/2019/4038619 |
Ejemplares similares
-
Monocyte Chemotactic Protein 1-Induced Protein 1 Is Highly Expressed in Inflammatory Bowel Disease and Negatively Regulates Neutrophil Activities
por: Lin, Jian, et al.
Publicado: (2020) -
Anti-TNF-α Therapy Suppresses Proinflammatory Activities of Mucosal Neutrophils in Inflammatory Bowel Disease
por: Zhang, Cui, et al.
Publicado: (2018) -
Hepcidin and sports anemia
por: Kong, Wei-Na, et al.
Publicado: (2014) -
Iron, anemia and hepcidin in malaria
por: Spottiswoode, Natasha, et al.
Publicado: (2014) -
Comparative evaluation of the effects of treatment with tocilizumab and TNF-α inhibitors on serum hepcidin, anemia response and disease activity in rheumatoid arthritis patients
por: Song, Soken-Nakazawa J, et al.
Publicado: (2013)